Genome-Wide Association Study of Celiac Disease in North America Confirms FRMD4B as New Celiac Locus by Garner, Chad et al.
Genome-Wide Association Study of Celiac Disease in
North America Confirms FRMD4B as New Celiac Locus
Chad Garner1*, Richard Ahn1, Yuan Chun Ding2, Linda Steele2, Samantha Stoven5, Peter H. Green3,
Alessio Fasano4, Joseph A. Murray5, Susan L. Neuhausen2
1 Epidemiology Department, School of Medicine, University of California Irvine, Irvine, California, United States of America, 2 Population Sciences Department, Beckman
Research Institute of City of Hope, Duarte, California, United States of America, 3Celiac Disease Center, Columbia University, New York City, New York, United States of
America, 4Center for Celiac Research, MassGeneral Hospital for Children, Boston, MA, United States of America, 5Division of Gastroenterology and Hepatology,
Department of Immunology, Mayo Clinic, Rochester, MN, United States of America
Abstract
We performed a genome-wide association study (GWAS) of 1550 North American celiac disease cases and 3084 controls.
Twelve SNPs, distributed across four regions (3p21.31, 4q27, 6q15, 6q25), were significantly associated with disease (p-value
,1.061027), and a further seven SNPs, across four additional regions (1q24.3, 10p15.1, 6q22.31, 17q21.32) had suggestive
evidence (1.061027 , p-value , 1.061026). This study replicated a previous suggestive association within FRMD4B
(3p14.1), confirming it as a celiac disease locus. All four regions with significant associations and two regions with
suggestive results (1q24.3, 10p15.1) were known disease loci. The 6q22.31 and 10p11.23 regions were not replicated. A total
of 410 SNPs distributed across the eight significant and suggestive regions were tested for association with dermatitis
herpetiformis and microscopic colitis. Preliminary, suggestive statistical evidence for association with the two traits was
found at chromosomes 3p21.31, 6q15, 6q25, 1q24.3 and 10p11.23, with future studies being required to validate the
reported associations.
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Introduction
Celiac disease is predominately a T cell-mediated immune
disease caused by sensitivity to the dietary protein gluten. It is
primarily a disease of Caucasians, with a population prevalence of
approximately 1%[1–3]. The role of the major histocompatibility
complex (MHC) in celiac disease was first reported 30 years ago
[4,5], with the identification of HLA-DQ2 almost 20 years ago [6].
At least 35% of the disease risk can be attributed to the necessary
high-risk HLA types. However, the HLA high-risk genotypes are
not sufficient to cause celiac disease. Genome-wide association
studies (GWAS) and follow-up studies have identified 40 non-HLA
loci that are associated with celiac disease, that combined explain
approximately 5% of the disease risk [7–11], leaving most of the
risk unexplained. In this study of North American celiac disease
cases, we conducted a GWAS to identify additional loci and to
confirm suspected loci. In addition, at the identified loci, we tested
the association of the celiac loci with dermatitis herpetiformis and
microscopic colitis. Dermatitis herpetiformis is regarded as an
alternative phenotypic expression of gluten-sensitive enteropathy,
with little known about the genetic contribution to this phenotype.
Microscopic colitis may coexist with celiac disease and is a
frequent cause of persistent diarrhea in such patients.
Materials and Methods
Subjects
The study included samples contributed by investigators within
the North American Celiac Disease Consortium, including Dr.
Susan Neuhausen at UC Irvine (now at City of Hope), Dr. Joe
Murray at the Mayo Clinic, Dr. Alesio Fasano at the University of
Maryland Celiac Disease Center, and Dr. Peter Green at
Columbia University. The resources from the four sites were
similar in that they used the same serological tests and collected
similar questionnaire data. To be considered a celiac case, the
individual must have tested serologically positive for IgA tTG
and/or IgA EMA and/or had a positive small intestinal biopsy. All
of the subjects from the Mayo Clinic and greater than 90% of the
subjects from UC Irvine/City of Hope and Columbia University
were biopsied. For those with serology only, using sequential
testing of IgA ttG followed by IgA EMA testing results in net
specificity rates of virtually 100% making it practical to accurately
identify those with celiac disease on the basis of serology alone
[12,13].
Celiac patients, recruited at City of Hope and Mayo Clinic,
were reviewed for concomitant diagnoses of dermatitis herpeti-
formis and microscopic colitis. The presence of dermatitis
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e101428
herpetiformis was based on either a confirmatory skin biopsy or
clinical documentation of the skin biopsy diagnosis in the medical
record that included demonstration of IgA deposits at the dermo-
epidermal junction. The presence of microscopic colitis was based
on either clinical documentation of the diagnosis in the medical
record or confirmatory colonic biopsies showing either lympho-
cytic or collagenous colitis.
The dbGaP (http://ncbi.nlm.nih.gov/gap/) data repository was
used as a source for population controls with GWAS genotype
data. Given the prevalence of celiac disease in populations of
European descent, the inclusion of population-based sampled
controls was expected to result in a negligible reduction in power
compared to an equal sized control sample of clinically defined
unaffected controls[14]. Data from two studies in dbGaP were
utilized because they had large numbers of controls with reported
European or Caucasian ancestry that were genotyped using the
same Illumina Human 660W Quad v.1A array platform used by
CIDR to genotype the celiac disease cases and unaffected controls
from the North American Celiac Disease Consortium described
above. The NHGRI eMERGE study called ‘‘GWAS on Cataract
and HLD in the PMRP’’ contributed genome-wide genotypes, age
and sex data for 1343 control samples. The NHGRI GENEVA
study called ‘‘NHGRI Genome-Wide Association Study of Venous
Thrombosis (GWAS of VTE)’’ contributed genome-wide geno-
types, age and sex data for an additional 1295 control samples.
Detailed information about both of these studies can be found at
the dbGaP website. The genotype data from these 2638 samples
from dbGaP were combined with the 530 CIDR-genotyped
unaffected controls, giving a total pre-QC control sample size of
3168.
Ethics Statement
All participants from studies downloaded from dbGaP provided
written informed consent under protocols approved by each
institution’s IRB, as required by dbGaP and posted on the dbGaP
website. All participants recruited from University of California
Irvine, City of Hope, Columbia University, Mayo Clinic and
University of Maryland signed informed consent at the time of
study enrollment under protocols approved by each of the
respective institutions’ IRBs. The subjects from UC Irvine and
City of Hope were collected under Dr. Neuhausen’s direction with
the University of California Irvine IRB approved protocol HS
2002-2521 and the City of Hope/Beckman Research Institute
IRB approved protocol 09169. Subjects from the Mayo Clinic
were collected under Dr. Murray’s direction with the Mayo Clinic
IRB approved protocol 1173-99. Subjects from the University of
Maryland were collected under the direction of Dr. Fasano with
the three University of Maryland IRB approved protocols H-
27784, H-29090, and H-29938. The samples from Columbia
University were collected under the direction of Dr. Green with
the two Columbia University IRB approved protocols 8562 and
AAAE8893.
Genotyping and Quality Control
Center for Inherited Disease Research (CIDR) completed the
GWAS genotyping of 1728 celiac disease cases and 530 controls
collected in the U.S. (funded by NIH R01 DK081645). The
following quality control assessments and corrections were taken
prior to the association analysis. All SNPs and samples with less
than 98% complete data were excluded from the analysis. SNPs
with allele frequencies less than 0.03 or genotype distributions that
failed to fit the Hardy-Weinberg equilibrium (HWE) model with a
p-value less than 1.061025 were filtered from the data. The
genotype data were used to test for unknown familial relationships
between subjects by analysis of the identity-by-state distribution of
the sample, misspecification of sex by analysis of chromosome X/
Y genotypes, and population substructure among the subjects by
multidimensional scaling of the computed identity-by-state matrix
and cluster analysis of the samples. Population genetic outliers
identified in the population substructure analysis were excluded
from the subsequent association analysis. Exclusions were made
when discrepancies could not be resolved. The GenABEL library
[15] of R statistical computing environment was used for the
quality control assessments.
SNP Association Analysis
The effect of the SNP genotypes on the dichotomous celiac
disease outcome was analyzed using logistic regression models. For
the GWAS analysis, the SNPs were coded as continuous variables,
with genotypes coded as 0, 1 or 2 to indicate the number of minor
alleles in the SNP. The statistical model included the sex of the
individual, and the computed principal components of the
genomic kinship matrix. There was no significant age effect
observed, so the variable was not included in the GWAS analysis.
Odds ratios and 95% confidence intervals were calculated from
the computed regression coefficients for the SNP genotype effect
and standard errors. The dermatitis herpetiformis and microscopic
colitis dichotomous phenotypes were analyzed for association
using a logistic regression model. All SNPs were analyzed with all
samples using a model that included celiac disease status and the
SNP as predictors. A second analysis of the two phenotypes
included only the celiac disease cases (case-only analysis) and the
genotype was the only predictor in the model. The GenABEL
library [15] of the R statistical computing environment was used
for all association analysis.
Results and Discussion
A sample of 1728 celiac disease cases and 3168 control
individuals were genotyped with the Illumina Human660W-Quad
SNP genotyping array for the GWAS. After extensive quality
control assessments of the SNPs and samples followed by
appropriate filtering, a set of 517,345 SNPs was analyzed in a
sample of 1550 cases and 3084 controls. Genome-wide statistical
significance was defined as a p-value for the association statistic of
less than 1.061027. SNPs showing p-values between 1.061026
and 1.061027 were labeled as having suggestive evidence for
association. The SNP association results from the previous celiac
disease GWAS and follow-up studies of Dubois et al [7] were used
to test for replication of the significant and suggestive findings
found in the current GWAS. This replication set included 3,796
cases and 8,154 controls; the samples genotyped on the Hap550
platform described in Dubois et al. [7].
Twelve SNPs met a genome-wide statistical significance
threshold of less than 1.061027 (Table 1). The SNPs were within
the known celiac disease loci on chromosomes 3p21.31, 4q27,
6p15 and 6p25.3, all of which showed significant association in the
previous GWAS and follow-up studies by Dubois et al. [7]. These
loci were subsequently included in a high-resolution association
analysis by Trynka et al. [10] to refine their positions. The locus on
chromosome 3p21.31 is intergenic between CCR3 and CCR2.
Chromosome 4q27 includes KIAA1109, ADAD1, IL2 and IL21 in a
single block of strong linkage disequilibrium. The locus on 6p15 is
within intron 2 of the BACH2 gene, and 6q25.3 includes the 59
UTR plus 4 kb of the TAGAP gene. Identification of these sites is
consistent with and confirms previous findings as to their locations
and odds ratios.
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Four regions showed suggestive evidence for association with
celiac disease, with these regions having at least one SNP meeting
suggestive evidence threshold and no SNPs showing significant
association (Table 1). Two SNPs on 10p15.1, rs4558075 and
rs10796045, provided suggestive evidence to the region, with the
SNPs having p-values of 0.013 and 0.014, respectively, for
replication. The analysis of the region carried out by Trynka
et al. [10] provided significant evidence for a celiac disease locus at
10p15.1. On chromosome 1q24.3, two SNPs in strong linkage
disequilibrium (LD) showed suggestive evidence for association
with celiac disease; however the SNPs showed no evidence for
association, or replication, in the Dubois et al. [7] study. In the
Dubois study, SNP rs859637 at 1q24.3 position 170,974,795
showed suggestive evidence for association, with GWAS and
follow-up study p-values of 8.1561025 and 5.6861023, respec-
tively. Subsequent analysis of the region by Trynka et al. [10]
identified two significant association signals across the approxi-
mately 300 kb region. The two SNPs shown in Table 1 (rs9286879
and rs2157453) mark one of the two signals reported by Trynka
et al. [10]. SNP rs859665 at position 170,931,065 on 1q24.3
showed a p-value of 4.4861024 in the GWAS and is in very weak
linkage disequilibrium with the two SNPs in the same region
shown in Table 1 (D’ = -0.404 and R2 = 0.025 between rs2157453
and rs859665). The SNPs rs859665 and rs2157453 showed
significant independent effects in a logistic regression model that
included both SNPs. The lack of replication observed for the two
1q24.3 SNPs shown in Table 1 can likely be attributed to sampling
variation and statistical chance. SNPs rs531930 and rs8081391 on
chromosomes 6q22.31 and 17q21.32, respectively, showed no
evidence for association in the Dubois et al. [7] study, indicating
that these suggestive results were most likely due to statistical
chance and are not marking a real celiac disease region.
Dubois et al [7] reported 13 SNPs in as many regions as
showing suggestive statistical evidence for association with celiac
disease; all 13 SNPs were genotyped and analyzed in the current
GWAS. Five of the suggestive SNP associations were subsequently
replicated by Trynka et al. [10] and are among the 40 known
celiac disease regions. We investigated the association results in the
current GWAS at these eight suggestive SNP loci that have not
been subsequently replicated to determine if there was evidence
for association in this North American study. Of the eight
previously suggestive but unreplicated SNPs, only SNP rs6806528
on chromosome 3p14.1 showed evidence for association in the
current GWAS. The associated region spans a 100 kb LD block.
The most significant association identified in this GWAS was at
rs4075188 with a p-value of 0.0012; the same SNP showed a p-
value of 3.7561025 in the Dubois et al. [7] study and was the most
significantly associated SNP in the region in that study. Figure 1
shows the results for all 17 SNPs across the LD block that were
analyzed in the current study and by Dubois et al. [7]. The greater
statistical significance reported by Dubois et al. [7] is a reflection of
the larger sample size. The Pearson correlation between the log-
transformed p-values of the two studies is 0.85 (p-value =
1.3361025). Under a null hypothesis of no association and
independence of the two samples, the very high correlation
between the results of the two studies is highly improbable.
Furthermore, the odds ratio estimates from the current and the
Dubois et al. [7] GWAS were consistent across the SNPs showing
association. The LD block lies completely within the FRMD4B
gene. FRMD4B is ubiquitously expressed and its product is
believed to be involved in the establishment of epithelial cell
polarity, and may also function as a scaffolding protein.
There were 410 SNPs genotyped within the eight LD blocks
containing the celiac associated regions shown in Table 1. These
410 SNPs were tested for association with the celiac-related
conditions dermatitis herpetiformis (DH) and microscopic colitis
(MC). Of the 1550 celiac disease cases in the study, 59 (3.8%) and
69 (4.5%) were positive for DH and MC, respectively. For DH,
most studies suggest that the prevalence of DH in celiac disease is
between 5 and 10%.[2] For MC, the prevalence in this study is
consistent with previous reports of 4.3% of celiac patients having
concomitant MC.[16] Microscopic colitis includes lymphocytic
colitis (LC) and collagenous colitis (CC). The association between
MC and celiac disease is well recognized, as both are associated
Figure 1. Association results for 17 SNPs from the current GWAS and the GWAS reported by Dubois et al. (REF) within the FRMD4B
gene on 3p14.1.
doi:10.1371/journal.pone.0101428.g001
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with HLA-DQ2.[17,18] For the case-control analysis, the geno-
type distributions of the 59 and 69 respective cases were compared
against all celiac cases without these conditions and the controls,
while adjusting for celiac disease status. The inclusion of the non-
phenotyped dbGaP controls was not expected to have a
detrimental effect on the statistical power given the rarity of the
conditions. The 17 SNPs were subsequently tested using only the
celiac disease cases in order to ensure that the results were not due
to residual confounding with celiac disease status. Table 2 shows
the association test results for the 17 SNPs that had p-values less
than 0.01 in the case-control analysis. None of the 410 tested SNPs
met a Bonferroni multiple test corrected p-value threshold of less
than 0.00012 (0.05/410).
SNPs on chromosomes 3p21.31, 6q15, 6q25.3 and 1q24.3
showed preliminary, suggestive evidence for association with MC
(uncorrected p-value ,0.01), with the smallest p-values observed
at chromosomes 6q15 (rs285640 p-value = 0.00058) and 6q25.3
(rs1738074 p-value = 0.00044). The 6q15 region is located within
an intron of BACH2. BACH2 codes for a transcription regulator
protein with a role in the regulation of B cells. In addition to its
known association with celiac disease, it is also associated with
ulcerative colitis, Crohn’s disease, and Type I diabetes melli-
tus.[19] At 6q25.3, the SNP rs1730874 was among the celiac
associated SNPs shown in Table 1 and it is located in the five
prime untranslated region (59 UTR) of TAGAP, a gene coding for a
GTPase-activating protein that is involved in T-cell activation.
This SNP, in addition to its association with celiac disease, is
associated with ulcerative colitis, particularly in ulcerative colitis
patients with a family history of the disease.[20]
At 3p21.31, SNP rs2234358 is located in the three prime
untranslated region (39 UTR) of CXCR6, a chemokine receptor on
T cells. CXCR6 has been associated with other colitides,
particularly Crohn’s disease. CYCL16, a ligand of CXCR6 has
been shown to be upregulated in colons of mouse models of
colitis[21] and increased CYCL16 serum levels have been
observed in patients with inflammatory bowel disease.[22] Also
in this region, SNPs rs1072755, rs4535265, rs3796375, rs737452
are intronic variants in FYCO1. FYCO1 codes for a protein
involved in autophagosome trafficking and has been associated
with congenital cataracts.[23] FYCO1 has not been previously
associated with colitides such as microscopic colitis; however
variants in other autophagy genes have been implicated in Crohn’s
disease.[24,25]
One SNP each on chromosomes 1q24.3 and 10p11.23 showed
preliminary, suggestive evidence for association with DH. At
1q24.3, SNPs rs2227203 and rs10798176 were associated with
MC and DH, respectively.
Table 2. Results of association analysis of microscopic colitis and dermatitis herpetiformis across celiac associated regions.
Case-Control Case-only
SNP Position Freq. P-value O.R. 95% C.I. P-value
Microscopic Colitis
Chromosome 3p21.31: 45,904,804–46,625,997
rs4683148 45,931,064 0.39 0.0044 1.66 1.17–2.35 0.0097
rs1072755 45,950,987 0.39 0.0034 1.68 1.19–2.37 0.0076
rs4535265 45,952,870 0.39 0.0037 1.68 1.18–2.38 0.013
rs2234358 45,964,048 0.49 0.0021 0.57 0.40–0.82 0.0019
rs3796375 45,983,794 0.42 0.0041 1.67 1.18–2.36 0.011
rs737452 46,002,414 0.42 0.0039 1.67 1.18–2.36 0.016
rs2373154 46,146,102 0.43 0.0045 1.66 1.17–2.35 0.0088
Chromosome 6q15: 90,863,556–91,096,529
rs207270 90,885,603 0.46 0.0095 1.59 1.12–2.27 0.011
rs4142967 91,053,070 0.46 0.0023 1.72 1.21–2.43 0.00044
rs12212193 91,053,490 0.46 0.0023 1.72 1.21–2.43 0.00044
rs285640 91,085,518 0.33 0.00058 0.45 0.29–0.71 0.0009
rs1847473 91,093,744 0.27 0.0018 1.74 1.23–2.46 0.0012
Chromosome 6q25.3: 159,242,314–159,461,818
rs1738074 159,385,965 0.43 0.00044 0.52 0.36–0.75 0.0041
rs2451241 159,441,116 0.43 0.0088 1.58 1.12–2.24 0.046
Chromosome 1q24.3: 170,917,308–171,207,073
rs2227203 171,145,646 0.46 0.0096 0.62 0.43–0.89 0.036
Dermatitis Herpetiformis
Chromosome 1q24.3: 170,917,308–171,207,073
rs10798176 170,942,148 0.16 0.00076 2.15 1.38–3.35 0.00025
Chromosome 10p11.23: 30,004,000–30,041,000
rs11007696 30,012,556 0.32 0.0052 0.51 0.32–0.82 0.0044
doi:10.1371/journal.pone.0101428.t002
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DH is an extraintestinal manifestation of celiac disease, with
virtually all patients carrying either HLA-DQ2 or DQ8 haplo-
types[26]. There are no known reasons for why DH manifests in
some celiac disease cases and not others. It may be that loci at
1q24.3 and 10p11.23 provide a permissive condition for the
development of the cutaneous disease, however, it is most probable
that the strongest genetic determinants of DH are not celiac
disease loci and will require a large, sufficiently powered GWAS of
the disease to be discovered.
Although the HLA genotypes are necessary for celiac disease,
they are common and insufficient to cause disease, and each
individual celiac patient will have a genetic etiology that includes
non-HLA disease alleles. Considerable progress has been made
towards elucidating the celiac loci with common disease alleles.
This report adds support to previously identified loci, and provides
statistical evidence for a celiac disease locus in the FRMD4B gene
on 3p14.1, providing the needed confirmation that it is a celiac
disease locus. This now brings the total number of identified loci
for celiac disease to 41. Furthermore, we found preliminary,
suggestive associations of MC and DH with celiac-associated loci
at chromosomes 3p21.31, 6q15, 6q25.3,1q24.3, and 10p11.23.
Further studies are needed to validate these findings.
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